Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 0781-3755

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 0781-3755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norepinephrine 01

Chemical structure of Norepinephrine Bitartrate, showing the molecular components including the norepinephrine moiety and the bitartrate component with associated hydroxyl and carboxyl groups, along with a water molecule (H2O).*

FDA Label Image

Norepinephrine 02

Packaging label for Norepinephrine Bitartrate Injection, USP 4 mg/4 mL (1 mg/mL) concentrate for intravenous infusion. The box contains 10 single-dose vials of 4 mL each. It includes dosing warnings, storage instructions like protecting from light, and is labeled for prescription use. Manufactured by Sandoz Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.